Muhammet Engin Özcan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammet Engin Özcan has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Abdulrahman Nor Abdi
Department of Pediatrics, Mogadishu Somali-Turkey Recep Tayyip Erdoğan Training and Research Hospital , Mogadishu, BN0052, Somalia
2 shared publications - Abdinur Abdullahi Hirsi
Department of Pediatric Surgery, Recep Tayyip Erdoğan Training and Research Hospital, Mogadishu, Somalia
1 shared publication - Abdishakur Mohamed Abdi
Department of Pediatric Surgery, Recep Tayyip Erdoğan Training and Research Hospital, Mogadishu, Somalia
1 shared publication Acil Tıp Kliniği
1 shared publication- Adem Küçük
Department of Pediatric Surgery, Recep Tayyip Erdoğan Training and Research Hospital, Mogadishu, Somalia
1 shared publication Ankara
1 shared publication
Latest Publications
- Open Access
- 4 November 2026
- Published by Springer Nature in BMC Pediatrics
Pediatric head and neck necrotizing fasciitis in Somalia: surgical management, VAC utilization, and reconstructive outcomes
- 4 November 2026
- Published by Springer Nature in BMC Pediatrics
Open AccessPediatric head and neck necrotizing fasciitis in Somalia: surgical management, VAC utilization, and reconstructive outcomes
- Open Access
- 14 October 2026
- Published by Hitit University in Hitit Medical Journal
- Vol. 8 (3) , 476-485
Diagnostic Performance of Serum Soluble HLA-G for Lung Cancer: A Case–Control Study
Objective: Human leukocyte antigen G (HLA-G) is a nonclassical class I molecule with immunosuppressive properties that may facilitate tumor immune escape. Elevated circulating soluble HLA-G (sHLA-G) levels have been reported in several malignancies. This study aimed to evaluate the diagnostic performance of serum sHLA-G levels in patients with lung cancer and to investigate whether smoking status influences these levels.Materials and Methods: This case–control study included 62 patients with newly diagnosed lung cancer, 40 smoker controls, and 31 nonsmoker healthy controls. Serum sHLA-G levels were measured using an enzyme-linked immunosorbent assay (ELISA). Statistical comparisons among groups were performed using one-way analysis of variance and correlation analyses. Receiver operating characteristic (ROC) curve analysis was conducted to assess the diagnostic performance of sHLA-G.Results: Mean serum sHLA-G levels were significantly higher in patients with lung cancer than in nonsmoker controls (16.14 ± 8.71 U/mL vs 10.21 ± 4.77 U/mL, p=0.04). When smoker and nonsmoker controls were combined, the difference remained significant (p
- 14 October 2026
- Published by Hitit University in Hitit Medical Journal
- Vol. 8 (3) , 476-485
Open AccessDiagnostic Performance of Serum Soluble HLA-G for Lung Cancer: A Case–Control Study
Objective: Human leukocyte antigen G (HLA-G) is a nonclassical class I molecule with immunosuppressive properties that may facilitate tumor immune escape. Elevated circulating soluble HLA-G (sHLA-G) levels have been reported in several malignancies. This study aimed to evaluate the diagnostic performance of serum sHLA-G levels in patients with lung cancer and to investigate whether smoking status influences these levels.Materials and Methods: This case–control study included 62 patients with newly diagnosed lung cancer, 40 smoker controls, and 31 nonsmoker healthy controls. Serum sHLA-G levels were measured using an enzyme-linked immunosorbent assay (ELISA). Statistical comparisons among groups were performed using one-way analysis of variance and correlation analyses. Receiver operating characteristic (ROC) curve analysis was conducted to assess the diagnostic performance of sHLA-G.Results: Mean serum sHLA-G levels were significantly higher in patients with lung cancer than in nonsmoker controls (16.14 ± 8.71 U/mL vs 10.21 ± 4.77 U/mL, p=0.04). When smoker and nonsmoker controls were combined, the difference remained significant (p
- 20 August 2026
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 72 (5)
Hidden vitamin D insufficiency in a sun-rich equatorial country: age-, sex-, and season-specific evidence from 2961 Somali children
This study aimed to determine the prevalence of vitamin D deficiency and insufficiency, and to evaluate age-, sex-, and season-specific variations in serum 25(OH)D levels among Somali children and adolescents. This retrospective cross-sectional study included pediatric outpatients aged 0–18 years who attended a tertiary care hospital in Mogadishu, Somalia, between January 2020 and August 2025. Serum 25(OH)D levels were analyzed in 2961 participants and categorized as deficient (20 ng/ml) according to Global Consensus Recommendations. Participants were stratified by age group, sex, and season. Statistical analyses were performed using non-parametric tests, with P < .05 considered statistically significant. Mean serum 25(OH)D levels decreased progressively with age, with the highest concentrations observed in infants aged 0–1 year (53.8 ± 18.1 ng/ml) and the lowest in adolescents aged 12–18 years (27.4 ± 13.1 ng/ml). Vitamin D deficiency was absent in infants and rare in children aged 1–6 years, but increased substantially in older age groups, reaching 9.4% deficiency and 23.7% insufficiency among adolescents. Males consistently exhibited higher serum 25(OH)D levels than females across all age groups and seasons (P < .001). Seasonal variation was observed, with the lowest mean levels recorded during July–September. Despite abundant year-round sunlight, vitamin D insufficiency and deficiency are prevalent among Somali children, particularly in adolescents and females. These findings highlight the need for age- and sex-specific public health strategies, including targeted screening and supplementation beyond early childhood, to improve 25(OH)D status in pediatric populations living in sun-rich environments.
- 20 August 2026
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 72 (5)
Hidden vitamin D insufficiency in a sun-rich equatorial country: age-, sex-, and season-specific evidence from 2961 Somali children
This study aimed to determine the prevalence of vitamin D deficiency and insufficiency, and to evaluate age-, sex-, and season-specific variations in serum 25(OH)D levels among Somali children and adolescents. This retrospective cross-sectional study included pediatric outpatients aged 0–18 years who attended a tertiary care hospital in Mogadishu, Somalia, between January 2020 and August 2025. Serum 25(OH)D levels were analyzed in 2961 participants and categorized as deficient (20 ng/ml) according to Global Consensus Recommendations. Participants were stratified by age group, sex, and season. Statistical analyses were performed using non-parametric tests, with P < .05 considered statistically significant. Mean serum 25(OH)D levels decreased progressively with age, with the highest concentrations observed in infants aged 0–1 year (53.8 ± 18.1 ng/ml) and the lowest in adolescents aged 12–18 years (27.4 ± 13.1 ng/ml). Vitamin D deficiency was absent in infants and rare in children aged 1–6 years, but increased substantially in older age groups, reaching 9.4% deficiency and 23.7% insufficiency among adolescents. Males consistently exhibited higher serum 25(OH)D levels than females across all age groups and seasons (P < .001). Seasonal variation was observed, with the lowest mean levels recorded during July–September. Despite abundant year-round sunlight, vitamin D insufficiency and deficiency are prevalent among Somali children, particularly in adolescents and females. These findings highlight the need for age- and sex-specific public health strategies, including targeted screening and supplementation beyond early childhood, to improve 25(OH)D status in pediatric populations living in sun-rich environments.
- Open Access
- 1 August 2026
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 19, 1-9
Hepatitis B, Hepatitis C, and HIV Seroprevalence and Their Association with Dialysis Adequacy and Glycaemic Parameters in Haemodialysis Patients: A Cross-Sectional Study from Somalia
Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections disproportionately affect haemodialysis (HD) patients in sub-Saharan Africa, yet Somali data remain scarce. We aimed to determine HBsAg, anti-HCV, and anti-HIV seroprevalence among HD patients in Mogadishu and to identify independent predictors of HBsAg seropositivity among measures of dialysis adequacy and glycaemic parameters. Methods: Single-centre retrospective cross-sectional study of 599 HD patients in Mogadishu, Somalia (June 2024–February 2026). Urea reduction ratio (URR) was calculated from pre- and post-dialysis urea. Bivariable comparisons used Mann–Whitney U, Fisher exact, and chi-square tests. Multivariable logistic regression assessed independent predictors of HBsAg positivity, adjusting for age, sex, fasting glucose, URR, and pre-dialysis creatinine (n=569 complete cases). Results: HBsAg positivity was 5.5% (33/599) and anti-HCV 2.3% (14/599); no patient was HIV-positive. HBsAg-positive patients were older, more frequently male, and had higher pre-dialysis urea, creatinine, URR, and fasting glucose (all p< 0.05), with equivalent post-dialysis clearance; HbA1c, AST, and ALT did not differ. Anti-HBs titres were near-absent in HBsAg-positive patients (0.3 vs 26.3 IU/L; p< 0.001). On multivariable analysis, older age (OR 1.023), male sex (OR 2.457), and higher URR (OR 1.031) independently predicted HBsAg positivity (AUROC 0.753); fasting glucose and creatinine were not independent after adjustment. With an events-per-variable ratio of 6.2, these findings are hypothesis-generating. Conclusion: Age, male sex, and URR not glycaemic or hepatic parameters independently predicted HBsAg positivity in this cohort. Near-absent anti-HBs titres indicate a critical vaccination gap, supporting universal hepatitis B screening, high-dose vaccination before dialysis initiation, and enhanced infection control in resource-limited settings.
- 1 August 2026
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 19, 1-9
Open AccessHepatitis B, Hepatitis C, and HIV Seroprevalence and Their Association with Dialysis Adequacy and Glycaemic Parameters in Haemodialysis Patients: A Cross-Sectional Study from Somalia
Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections disproportionately affect haemodialysis (HD) patients in sub-Saharan Africa, yet Somali data remain scarce. We aimed to determine HBsAg, anti-HCV, and anti-HIV seroprevalence among HD patients in Mogadishu and to identify independent predictors of HBsAg seropositivity among measures of dialysis adequacy and glycaemic parameters. Methods: Single-centre retrospective cross-sectional study of 599 HD patients in Mogadishu, Somalia (June 2024–February 2026). Urea reduction ratio (URR) was calculated from pre- and post-dialysis urea. Bivariable comparisons used Mann–Whitney U, Fisher exact, and chi-square tests. Multivariable logistic regression assessed independent predictors of HBsAg positivity, adjusting for age, sex, fasting glucose, URR, and pre-dialysis creatinine (n=569 complete cases). Results: HBsAg positivity was 5.5% (33/599) and anti-HCV 2.3% (14/599); no patient was HIV-positive. HBsAg-positive patients were older, more frequently male, and had higher pre-dialysis urea, creatinine, URR, and fasting glucose (all p< 0.05), with equivalent post-dialysis clearance; HbA1c, AST, and ALT did not differ. Anti-HBs titres were near-absent in HBsAg-positive patients (0.3 vs 26.3 IU/L; p< 0.001). On multivariable analysis, older age (OR 1.023), male sex (OR 2.457), and higher URR (OR 1.031) independently predicted HBsAg positivity (AUROC 0.753); fasting glucose and creatinine were not independent after adjustment. With an events-per-variable ratio of 6.2, these findings are hypothesis-generating. Conclusion: Age, male sex, and URR not glycaemic or hepatic parameters independently predicted HBsAg positivity in this cohort. Near-absent anti-HBs titres indicate a critical vaccination gap, supporting universal hepatitis B screening, high-dose vaccination before dialysis initiation, and enhanced infection control in resource-limited settings.
- Open Access
- 17 November 2022
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 35 (4) , 215-219
Evaluation of the Relationship Between Disease Severity and Viral Cycle Threshold Value in COVID-19 Patients
Objective: There is a positive and significant relationship between severity and viral load in some viral diseases. Studies on the relationship between SARS-CoV-2 viral load at diagnosis and severity of coronavirus disease-2019 (COVID-19) have yielded conflicting results. Therefore, we aimed to evaluate the relationship between viral load and the clinical status of patients with COVID-19. Methods: Data of the patients diagnosed with COVID-19 and admitted to our center between May 01 and June 31, 2020, were retrospectively reviewed. The patients were divided into two groups according to their clinical characteristics as mild-moderate and severe. The demographic, laboratory, clinical, and radiological data were retrieved from electronic folders. Results: The entire cohort included 285 patients; 254 had a mild-moderate clinical course, and 31 had a severe course. Statistical analyses revealed that SARS-CoV-2 viral load was not associated with symptom duration and clinical status (p>0.05). According to multivariate logistic regression analysis, only ferritin, C-reactive protein, and lactate dehydrogenase elevations were positively correlated with severe clinical course. (p<0.05). Conclusion: We do not recommend using viral load to predict disease severity in COVID-19. We also found that only ferritin, C-reactive protein, and lactate dehydrogenase accompanied severe clinical course.
- 17 November 2022
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 35 (4) , 215-219
Open AccessEvaluation of the Relationship Between Disease Severity and Viral Cycle Threshold Value in COVID-19 Patients
Objective: There is a positive and significant relationship between severity and viral load in some viral diseases. Studies on the relationship between SARS-CoV-2 viral load at diagnosis and severity of coronavirus disease-2019 (COVID-19) have yielded conflicting results. Therefore, we aimed to evaluate the relationship between viral load and the clinical status of patients with COVID-19. Methods: Data of the patients diagnosed with COVID-19 and admitted to our center between May 01 and June 31, 2020, were retrospectively reviewed. The patients were divided into two groups according to their clinical characteristics as mild-moderate and severe. The demographic, laboratory, clinical, and radiological data were retrieved from electronic folders. Results: The entire cohort included 285 patients; 254 had a mild-moderate clinical course, and 31 had a severe course. Statistical analyses revealed that SARS-CoV-2 viral load was not associated with symptom duration and clinical status (p>0.05). According to multivariate logistic regression analysis, only ferritin, C-reactive protein, and lactate dehydrogenase elevations were positively correlated with severe clinical course. (p<0.05). Conclusion: We do not recommend using viral load to predict disease severity in COVID-19. We also found that only ferritin, C-reactive protein, and lactate dehydrogenase accompanied severe clinical course.